Methods: This is a prospective cohort study conducted in the critical care unit of a subspecialty hospital between August 2017 to January 2018 involving mechanically ventilated patients suspected with VAP. The PCT level was obtained from the qualified subjects on the day of VAP suspicion. All tests were done using enzyme-linked fluorescent assay technique. Receiver operating characteristics analysis was used to determine the diagnostic parameters of PCT. The population was divided into VAP and no-VAP group.
Background and Aims: Surgical procedures are recommended for parapneumonic empyema (PE) in the advanced stages. The role of video-assisted flexible thoracoscopic (VAFTS) debridement via a single trocar under local anaesthesia for multiloculated PE has not been established, although some studies have reported on VAFTS debridement cases. We explored the effectiveness and safety of VAFTS debridement under local anaesthesia for multiloculated PE and the preoperative clinical features that affect the success of the procedure.
Methods:
We retrospectively reviewed the medical records of patients who underwent VAFTS debridement under local anaesthesia for multiloculated PE from January 2007 to December 2017. The baseline patient data, including haematology, radiologic findings, and bacterial examinations, were collected. The primary outcome was hospital mortality without additional operation under general anaesthesia. The potential predictors were analyzed for possible association with the outcomes.
Results: A total of 69 patients with multiloculated PE were treated by VAFTS debridement. Based on the Light classification, infection was staged as class 5 in 45 patients and as class 7 in 24 patients. The average onset of symptoms was 13.3 AE 13.8 days before the procedure. VAFTS debridement was successful in 59 patients (85.5%); 7 patients required subsequent operation under general anaesthesia and 3 patients died due to sepsis. Complications occurred in 3 patients (4.3%). A microbiological diagnosis could be made in 26 patients (44.1%). Multivariate logistic regression analysis revealed that leukocytosis of >15,000/μL (P = 0.016) and duration from the onset of symptoms to the procedure (P = 0.010) were independently associated with the success of this procedure.
Conclusion:
Single-trocar VAFTS debridement can be an acceptable first choice of treatment in patients with multiloculated PE. Importantly, this procedure should be performed as early as possible for a successful outcome and to obtain useful information on the nature of the pleural effusion and the status of the pleural cavity. Background and Aims: Pneumonia is a significant contributor to morbidity and mortality. Current Australian treatment guidelines on community-acquired pneumonia recommend performing blood cultures on all hospitalised patients and urinary antigen testing in severe disease, based on the SMART-COP or CORB severity scores. However, diagnostic yield for aetiology remains low.
The availability of urinary antigen testing for S. pneumoniae and Legionella pneumophilia has enabled rapid aetiological diagnosis and directed included. Medical records were reviewed to evaluate the proportion of cases where antibiotic treatment was de-escalated in the setting of a positive urinary antigen result. Observance of local guidelines for diagnostic testing and evaluation of cost-benefit analysis of urinary antigens were also assessed.
Results: Preliminary results demonstrate a low prevalence of positive urinary antigen in our study population. Positive urinary antigen tests resulted in de-escalation from empirical to targeted antibiotics in only a small proportion of cases.
The diagnostic and clinical utility of pneumococcal and legionella urinary antigens is low in community-acquired pneumonia. Due to the low prevalence of positive urinary antigen results, routine testing in hospitalised patients is not cost-effective. Nagasaki University School of Medicine, Japan Background and Aims: The Diagnostic Procedure Combination (DPC), which is a huge inpatient database and links with a lump-sum payment system that has introduced by the Japanese government in 2002, has been actively used for evaluating pneumonia patients. According to the 2017 Japanese guidelines, it is weakly recommended to add low-dose corticosteroid to antibiotic therapy for severe pneumonia patients. However, the efficacy of corticosteroid add-on therapy for severe communityonset pneumonia patients remains unclear. We therefore evaluated the efficacy of corticosteroid add-on treatment for severe pneumonia using the DPC database.
Methods: Adult patients with severe community-onset pneumonia patients (more than 3 points in the A-DROP system) treated in hospital between January and December 2012 were identified in the DPC database. The background factors were adjusted using the inverse probability of treatment weighting (IPTW) method, and the patients that high-dose corticosteroids (methylprednisolone ≧500 mg/day) were administered were excluded. The patients were divided into two groups based on the presence or absence of low-dose corticosteroid treatment in addition to antibiotic therapy. The 30-day survival rate was evaluated using the Kaplan-Meier method.
Results: The average ages and male ratios of the corticosteroid addon (A) group (1,338 patients) and corticosteroid non-add-on (B) group (11,939 patients) were 81.6 and 83.4 years old, 67.2% and 61.0%, respectively. We found no significant differences of the 30-day survival rate between A and B group (weighted hazard ratio: 1.08; 95% confidence interval: 0.91-1.29; P = 0.38).
Conclusion: Low-dose corticosteroid add-on therapy in addition to antibiotic medication for severe community-onset pneumonia patients may not be related to an improvement of the prognosis. Background and Aims: Identification of the reasons and risk factors associated with readmission is important concerning discharge planning. The purpose of this study was to clarify the rates, reasons and risk factors associated with 30 day readmission following hospitalization for community-acquired pneumonia (CAP).
Methods: We performed a retrospective observational study of 1,021 patients with CAP who were hospitalized at Yeungnam University Hospital between March 2012 and February 2014. The primary end point was all-cause readmissions to the hospital within the 30 days following discharge after initial hospitalization. Hospital readmission was classified as (1) pneumonia-related readmission or (2) pneumonia-unrelated readmission.
Results: During the study period, 1,021 patients were eligible for the study. 121 patients died during the initial hospitalization, 35 patients discharged against medical advice and refused outpatient follow up, and 3 patients transferred to another acute care facility. Of the 862 patients who survived to hospital discharge, 72 (8.4%) were rehospitalized within 30 days following discharge. Pneumonia-related causes accounted for 37.5% (27 patients) and pneumonia-unrelated causes accounted for 62.5% (45 patients) of the total reasons for 30 day readmission. In the multivariable analysis, pneumonia related hospital readmission was associated with para/hemiplegia, malignancy, pneumonia severity index (PSI) class ≥4 and clinical instability ≥1 at hospital discharge. Underlying comorbidities such as chronic lung disease, chronic kidney disease, hospitalization for ≥2 days during the preceding 90 days, treatment failure and decompensation of comorbidities were associated with pneumoniaunrelated hospital readmission within 30 days.
Rehospitalizations within 30 days following discharge were frequent among patients with CAP. Different risk factors are associated with hospital readmission related to pneumonia or to pneumoniaunrelated causes. Identification of the risk factors associated with hospital readmission in two different groups might have implications for discharge planning and follow up of patients with CAP. Background and Aims: Echinococcosis or hydatid disease is caused by larvae of the tapeworm Echinococcus. Four species are recognised and the vast majority of infestation in humans are caused by E. granulosus. It causes cystic echinococcosis, which has a worlwide distribution most commonly in Asia. Humans are exposed less frequently to E. multilocularis, which causes alveolar echinococcosis. E. vogeli and E .oligarthrus are rare species and cause polycystic echinoccosis.
Methods: case report-A 26 year old female from Afghanistan has presented with complains of cough with white sputum, low grade fever. Left side chest pain since around 2 months. No history of TB in past, history of exposure to sheep present. Blood report shows normal TLC with raised 30 % eosinophil count, chest X-ray shows b/l opacity well rounded involving lower lobes. Diagnosis was not made so advised HRCT chest, which shows multiple well rounded thin walled cysts of variable size
